Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Drug Resistance

  Free Subscription


27.08.2018

1 Antimicrob Agents Chemother
9 Int J Antimicrob Agents
2 J Infect Chemother
1 Lancet Infect Dis
1 Nature
1 Proc Natl Acad Sci U S A


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. MA P, Laibinis HH, Ernst CM, Hung DT, et al
    Carbapenem resistance caused by high-level expression of OXA-663 beta-lactamase in an OmpK36-deficient Klebsiella pneumoniae clinical isolate.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01281.
    PubMed     Text format     Abstract available


    Int J Antimicrob Agents

  2. HE J, Jia X, Yang S, Xu X, et al
    Heteroresistance to carbapenems in invasive Pseudomonas aeruginosa infections.
    Int J Antimicrob Agents. 2018;51:413-421.
    PubMed     Text format     Abstract available

  3. TACAO M, Araujo S, Vendas M, Alves A, et al
    Shewanella species as the origin of blaOXA-48 genes: insights into gene diversity, associated phenotypes and possible transfer mechanisms.
    Int J Antimicrob Agents. 2018;51:340-348.
    PubMed     Text format     Abstract available

  4. CHIEN YC, Liao CH, Sheng WH, Chien JY, et al
    Clinical characteristics of bacteraemia caused by Burkholderia cepacia complex species and antimicrobial susceptibility of the isolates in a medical centre in Taiwan.
    Int J Antimicrob Agents. 2018;51:357-364.
    PubMed     Text format     Abstract available

  5. BRAUN G, Cayo R, Matos AP, de Mello Fonseca J, et al
    Temporal evolution of polymyxin B-resistant Klebsiella pneumoniae clones recovered from blood cultures in a teaching hospital during a 7-year period.
    Int J Antimicrob Agents. 2018;51:522-527.
    PubMed     Text format     Abstract available

  6. KHAN DD, Lagerback P, Malmberg C, Kristoffersson AN, et al
    Predicting mutant selection in competition experiments with ciprofloxacin-exposed Escherichia coli.
    Int J Antimicrob Agents. 2018;51:399-406.
    PubMed     Text format     Abstract available

  7. BOUSQUET A, Bugier S, Larreche S, Bigaillon C, et al
    Clinical isolates of Escherichia coli solely resistant to mecillinam: prevalence and epidemiology.
    Int J Antimicrob Agents. 2018;51:493-497.
    PubMed     Text format     Abstract available

  8. DIETL B, Sanchez I, Arcenillas P, Cuchi E, et al
    Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes.
    Int J Antimicrob Agents. 2018;51:498-502.
    PubMed     Text format     Abstract available

  9. JONES BM, Hersey RM, Trestman IJ, Bland CM, et al
    Successful treatment of a penicillin-intermediate and ceftriaxone-resistant Granulicatella adiacens presumed prosthetic valve endocarditis with vancomycin.
    Int J Antimicrob Agents. 2018;51:508-510.
    PubMed     Text format     Abstract available

  10. VINUE L, Hooper DC, Jacoby GA
    Chromosomal mutations that accompany qnr in clinical isolates of Escherichia coli.
    Int J Antimicrob Agents. 2018;51:479-483.
    PubMed     Text format     Abstract available


    J Infect Chemother

  11. NAKANISHI N, Nomoto R, Sato K, Koike C, et al
    Acquisition of antimicrobial-resistant variants in repeated infections caused by Pseudomonas aeruginosa revealed by whole genome sequencing.
    J Infect Chemother. 2018 Aug 17. pii: S1341-321X(18)30237.
    PubMed     Text format     Abstract available

  12. CHO EH, Huh HJ, Song DJ, Moon SM, et al
    Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    J Infect Chemother. 2018;24:315-318.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  13. VIHTA KD, Stoesser N, Llewelyn MJ, Quan TP, et al
    Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health records.
    Lancet Infect Dis. 2018 Aug 17. pii: S1473-3099(18)30353.
    PubMed     Text format     Abstract available


    Nature

  14. GILBERT N
    Four stories of antibacterial breakthroughs.
    Nature. 2018;555:S5-S7.
    PubMed     Text format    


    Proc Natl Acad Sci U S A

  15. KLEIN EY, Van Boeckel TP, Martinez EM, Pant S, et al
    Global increase and geographic convergence in antibiotic consumption between 2000 and 2015.
    Proc Natl Acad Sci U S A. 2018;115:E3463-E3470.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: